Literature DB >> 9475506

Brain acetylcholinesterase promotes amyloid-beta-peptide aggregation but does not hydrolyze amyloid precursor protein peptides.

E O Campos1, A Alvarez, N C Inestrosa.   

Abstract

It has been suggested that acetylcholinesterase (AChE) has both a putative proteolytic activity against the amyloid precursor protein (APP), and a capacity to accelerate the assembly of amyloid-beta-peptide (Abeta) into Alzheimer's fibrils. Here, we have studied the ability of bovine brain AChE to share both activities. Results indicate that AChE purified through acridinium was able to process the APP peptides, however after further purification by an edrophonium column, the protease activity was lost. Under both conditions the capacity of the enzyme to promote amyloid formation was maintained. Kinetic studies of the Abeta aggregation process using edrophonium-AChE, indicated that the lag phase of the aggregation process was smaller than the one observed with the esterase purified by acridinium alone. Considering that the total amount of amyloid formed, measured by thioflavine-T fluorescence, was similar for both AChE preparations, our results suggest that the edrophonium-AChE possesses an higher intrinsic capacity to stimulate the aggregation of Abeta(1-40) peptide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475506     DOI: 10.1023/a:1022416505725

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

1.  Acetylcholinesterase-catalyzed hydrolysis of an amide.

Authors:  D E Moore; G P Hess
Journal:  Biochemistry       Date:  1975-06-03       Impact factor: 3.162

2.  Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.

Authors:  A Alvarez; C Opazo; R Alarcón; J Garrido; N C Inestrosa
Journal:  J Mol Biol       Date:  1997-09-26       Impact factor: 5.469

3.  Peptidasic activities associated with acetylcholinesterase are due to contaminating enzymes.

Authors:  F Checler; J P Vincent
Journal:  J Neurochem       Date:  1989-09       Impact factor: 5.372

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.

Authors:  C I Wright; C Guela; M M Mesulam
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

6.  Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterases in other tissues.

Authors:  N C Inestrosa; W L Roberts; T L Marshall; T L Rosenberry
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

7.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

8.  Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice.

Authors:  R Beeri; C Andres; E Lev-Lehman; R Timberg; T Huberman; M Shani; H Soreq
Journal:  Curr Biol       Date:  1995-09-01       Impact factor: 10.834

9.  Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

Authors:  N C Inestrosa; A Alvarez; C A Pérez; R D Moreno; M Vicente; C Linker; O I Casanueva; C Soto; J Garrido
Journal:  Neuron       Date:  1996-04       Impact factor: 17.173

10.  Proteolysis at the secretase and amyloidogenic cleavage sites of the beta-amyloid precursor protein by acetylcholinesterase and butyrylcholinesterase using model peptide substrates.

Authors:  M de Serres; D Sherman; W Chestnut; B M Merrill; O H Viveros; E J Diliberto
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

View more
  4 in total

Review 1.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 2.  Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.

Authors:  Maria Laura Bolognesi; Andrea Cavalli; Carlo Melchiorre
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

3.  Comparative Evaluation of Prosopis cineraria (L.) Druce and Its ZnO Nanoparticles on Scopolamine Induced Amnesia.

Authors:  Ekta Yadav; Deepika Singh; Pankajkumar Yadav; Amita Verma
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

4.  Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and in vitro study to explore novel AChE inhibitors.

Authors:  Srabanti Jana; Ankit Ganeshpurkar; Sushil Kumar Singh
Journal:  RSC Adv       Date:  2018-11-26       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.